Current perspectives on drug treatment for preterm labour
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 18 (4) , 309-314
- https://doi.org/10.1080/01443619867001
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Treatment of Preterm Labor with the Oxytocin Antagonist AtosibanAmerican Journal of Perinatology, 1996
- The effect of the oxytocin antagonists F314 and F792 on the in vitvo contractility of human myometriumBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- New perspectives for the effective treatment of preterm laborAmerican Journal of Obstetrics and Gynecology, 1995
- Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: Effects of the oxytocin antagonist atosibanAmerican Journal of Obstetrics and Gynecology, 1994
- Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donorThe Lancet, 1994
- The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanAmerican Journal of Obstetrics and Gynecology, 1994
- Changes in amniotic arachidonic acid metabolism associated with increased cyclo-oxygenase gene expressionBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist RitodrineNew England Journal of Medicine, 1992
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- The disposition of sulindacClinical Pharmacology & Therapeutics, 1977